Also trades as: XTLB.TA (TLV) · $vol 0M
XTLB NASDAQ
XTL Biopharmaceuticals Ltd.
1W: -1.8%
1M: -18.8%
3M: -31.2%
YTD: +260.3%
1Y: +87.8%
3Y: +109.7%
5Y: -47.5%
$2.16
+0.03 (+1.41%)
Weekly Expected Move ±9.6%
$2
$2
$2
$2
$3
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Income Trends
Revenue
$451K
+0.0% ▲
Gross Profit
$3K
+0.0% ▲
Operating Income
-$2M
-183.9% ▼
Net Income
-$1M
-57531.9% ▼
EPS (Diluted)
$-0.15
+0.0% ▲
EBITDA
-$930K
-21.7% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $451K |
| YoY Growth | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% |
| Cost of Revenue | $1K | $1K | $1K | $0 | $448K |
| Gross Profit | -$1K | -$1K | -$1K | $0 | $3K |
| Gross Margin | — | — | — | — | 0.7% |
| R&D Expenses | $38K | $30K | $30K | $31K | $98K |
| SG&A Expenses | $910K | $1M | $850K | $734K | $2M |
| Operating Expenses | $948K | $1M | $880K | $765K | $2M |
| Operating Income | -$948K | -$1M | -$880K | -$765K | -$2M |
| Operating Margin | — | — | — | — | -481.6% |
| Interest Expense | $17K | $21K | $11K | $4K | $86K |
| Income Before Tax | -$3M | $435K | -$1M | -$2M | -$1M |
| Tax Expense | $0 | $0 | $0 | $0 | -$130K |
| Net Income | -$782K | $435K | -$1M | -$2K | -$1M |
| Net Margin | — | — | — | — | -227.7% |
| EPS (Diluted) | $-0.57 | $0.07 | $-0.25 | $0.00 | $-0.15 |
| EBITDA | -$947K | -$1M | -$879K | -$764K | -$930K |
| Shares Outstanding | 5M | 6M | 5M | 5M | 7M |